Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,262,546 papers from all fields of science
Search
Sign In
Create Free Account
Eflornithine Hydrochloride
Known as:
Eflornithine.HCl
, Hydrochloride, Eflornithine
, Eflornithine Monohydrochloride, Monohydrate
Expand
The hydrochloride form of eflornithine, a difluoromethylated ornithine compound with antineoplastic activity. Eflornithine irreversibly inhibits…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
African Trypanosomiasis
Antiprotozoal Agents
Decarboxylase Inhibitors [MoA]
Decreased Protein Synthesis [PE]
Expand
Broader (1)
Eflornithine
Narrower (1)
Vaniqa
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Androgen excess: Investigations and management.
Daria Lizneva
,
L. Gavrilova-Jordan
,
Walidah Walker
,
R. Azziz
Best Practice & Research: Clinical Obstetrics…
2016
Corpus ID: 26062108
Highly Cited
2013
Highly Cited
2013
Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo.
E. Alirol
,
D. Schrumpf
,
+4 authors
F. Chappuis
Clinical Infectious Diseases
2013
Corpus ID: 10123149
BACKGROUND Existing diagnostic and treatment tools for human African trypanosomiasis (HAT) are limited. The recent development of…
Expand
Highly Cited
2011
Highly Cited
2011
Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6
N. Baker
,
S. Alsford
,
D. Horn
Molecular and biochemical parasitology (Print)
2011
Corpus ID: 12920974
Highly Cited
2010
Highly Cited
2010
Cross-Resistance to Nitro Drugs and Implications for Treatment of Human African Trypanosomiasis
A. Y. Sokolova
,
S. Wyllie
,
Stephen Patterson
,
Sandra L. Oza
,
K. Read
,
A. Fairlamb
Antimicrobial Agents and Chemotherapy
2010
Corpus ID: 2708956
ABSTRACT The success of nifurtimox-eflornithine combination therapy (NECT) for the treatment of human African trypanosomiasis…
Expand
Review
2010
Review
2010
NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping Sickness
O. Yun
,
G. Priotto
,
J. Tong
,
Laurence Flévaud
,
F. Chappuis
PLoS Neglected Tropical Diseases
2010
Corpus ID: 2776361
Fatal if untreated, human African trypanosomiasis (HAT; sleeping sickness) afflicts an estimated 50,000–70,000 people each year…
Expand
Highly Cited
2007
Highly Cited
2007
Randomized, double‐blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair
J. Wolf
,
D. Shander
,
+4 authors
K. Schrode
International Journal of Dermatology
2007
Corpus ID: 10795478
Greater than 40% of women in the USA have unwanted facial hair. 1 The condition can have a profound impact on a woman’s self…
Expand
Highly Cited
2006
Highly Cited
2006
Three Drug Combinations for Late-Stage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in Uganda
G. Priotto
,
C. Fogg
,
+5 authors
P. Piola
PLoS Clinical Trials
2006
Corpus ID: 9732532
Objectives: Our objective was to compare the efficacy and safety of three drug combinations for the treatment of late-stage human…
Expand
Review
2003
Review
2003
The evaluation and management of hirsutism.
R. Azziz
Obstetrics and Gynecology
2003
Corpus ID: 1617103
Review
2001
Review
2001
Topical Eflornithine
J. Balfour
,
K. McClellan
American Journal of Clinical Dermatology
2001
Corpus ID: 26181011
Abstract▴ Eflornithine is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase which is thought to slow hair…
Expand
Highly Cited
1992
Highly Cited
1992
Treatment of recurrent gliomas with eflornithine.
V. Levin
,
M. Prados
,
W. Yung
,
M. J. Gleason
,
S. Ictech
,
M. Malec
Journal of the National Cancer Institute
1992
Corpus ID: 39049436
BACKGROUND Oral eflornithine in combination with intravenous mitoguazone (methylbisguanylhydrazone) has shown activity against…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE